DR ROBERT BOLDERMAN
Turnover is estimated at about €610,000, probably between €540,000 and €850,000. The abbreviated or micro format does not state turnover.
Balance sheet
balance sheet total €685,993 on 31-12-2025in €m
in euro
Position in the sector
94.7%
Higher than 91% of the 21,385 companies filing micro accounts in human health (NACE 86) in 2025.
20.13
Higher than 92% of the 20,936 companies filing micro accounts in human health (NACE 86) in 2025.
43.2%
Higher than 78% of the 21,236 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 202011 months |
|---|---|---|---|---|---|---|---|
| 404,197 | 411,606 | 384,810 | 438,689 | 259,424 | 109,847 | ||
| 311,230 | 316,616 | 296,610 | 335,955 | 200,999 | 88,107 | ||
| 6,346 | 0 | 9,926 | 22,191 | 0 | 76,496 | ||
| -322,622 | 230,112 | 142,924 | 164,627 | 159,192 | - | ||
| 640,405 | 1.0m | 697,010 | 532,494 | 220,426 | 16,611 | ||
| 94.7% | 97.1% | 89.3% | 88.5% | 68.6% | 50.8% | ||
| 20.13 | 36.29 | 9.06 | 8.00 | 2.80 | 1.19 | ||
| 0.06 | 0.03 | 0.12 | 0.13 | 0.46 | 0.97 | ||
| 45.6% | 29.1% | 38.5% | 53.8% | 67.5% | 94.4% | ||
| 43.2% | 28.3% | 34.4% | 47.7% | 46.3% | 47.9% | ||
| over 100 | over 100 | over 100 | over 100 | over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 202011 months |
|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||
20/58 |
685,993 | 1.1m | 819,838 | 671,977 | 400,030 | 175,898 | |
21/28 |
12,112 | 20,706 | 36,380 | 63,433 | 56,953 | 72,664 | |
22/27 |
11,912 | 20,506 | 36,180 | 41,242 | 56,953 | 72,664 | |
24 |
4,278 | 11,880 | 26,561 | 41,242 | 56,953 | 72,664 | |
26 |
7,634 | 8,626 | 9,619 | - | - | - | |
28 |
200 | 200 | 200 | 22,191 | - | - | |
29/58 |
673,881 | 1.0m | 783,459 | 608,543 | 343,076 | 103,233 | |
40/41 |
267,512 | 314,400 | 284,716 | 251,171 | 152,029 | 68,698 | |
40 |
236,334 | 285,400 | 246,921 | 241,853 | 152,029 | 68,698 | |
41 |
31,178 | 29,000 | 37,794 | 9,317 | - | - | |
54/58 |
403,192 | 725,814 | 495,701 | 352,777 | 188,150 | 28,958 | |
490/1 |
3,177 | 3,121 | 3,042 | 4,596 | 2,897 | 5,577 | |
| Balance sheet: equity and liabilities | |||||||
10/49 |
685,993 | 1.1m | 819,838 | 671,977 | 400,030 | 175,898 | |
10/15 |
649,661 | 1.0m | 732,429 | 594,808 | 274,563 | 89,276 | |
10/11 |
5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |
11 |
- | - | - | - | - | 5,000 | |
1109/19 |
- | - | - | - | - | 5,000 | |
13 |
644,661 | 1.0m | 727,429 | 589,808 | 269,563 | 84,276 | |
133 |
644,661 | 1.0m | 727,429 | 589,808 | 269,563 | 84,276 | |
17/49 |
36,332 | 30,670 | 87,409 | 77,169 | 125,466 | 86,622 | |
42/48 |
33,476 | 28,750 | 86,449 | 76,049 | 122,650 | 86,622 | |
44 |
- | 985 | 1,439 | - | 812 | 631 | |
440/4 |
- | 985 | 1,439 | - | 812 | 631 | |
45 |
4,800 | 7,717 | 17,300 | 62,455 | 62,415 | 25,444 | |
450/3 |
4,800 | 7,717 | 14,550 | 59,705 | 59,665 | 22,694 | |
454/9 |
- | - | 2,750 | 2,750 | 2,750 | 2,750 | |
47/48 |
28,676 | 20,048 | 67,710 | 13,594 | 59,423 | 60,547 | |
492/3 |
2,856 | 1,920 | 960 | 1,120 | 2,816 | - | |
| Income statement | |||||||
9900 |
404,325 | 411,732 | 384,975 | 438,801 | 259,535 | 109,897 | |
630 |
14,941 | 15,673 | 14,988 | 15,711 | 15,711 | 3,831 | |
640/8 |
128 | 126 | 165 | 112 | 111 | 50 | |
9901 |
389,256 | 395,933 | 369,822 | 422,978 | 243,713 | 106,016 | |
75/76B |
- | - | 1 | - | - | - | |
75 |
- | - | 1 | - | - | - | |
65/66B |
145 | 74 | 69 | 1,440 | 2,487 | 46 | |
65 |
145 | 74 | 69 | 1,440 | 2,487 | 46 | |
9903 |
389,111 | 395,859 | 369,754 | 421,538 | 241,226 | 105,969 | |
67/77 |
92,822 | 94,917 | 88,132 | 101,294 | 55,938 | 21,694 | |
9904 |
296,289 | 300,942 | 281,622 | 320,244 | 185,288 | 84,276 | |
9905 |
296,289 | 300,942 | 281,622 | 320,244 | 185,288 | 84,276 | |
| Appropriation of the result | |||||||
9906 |
296,289 | 300,942 | 281,622 | 320,244 | 185,288 | 84,276 | |
791/2 |
680,000 | - | 85,000 | - | - | - | |
691/2 |
296,289 | 300,942 | 222,622 | 320,244 | 185,288 | 84,276 | |
6921 |
296,289 | 300,942 | 222,622 | 320,244 | 185,288 | 84,276 | |
694/7 |
680,000 | - | 144,000 | - | - | - | |
694 |
680,000 | - | 144,000 | - | - | - | |
| Document | |||||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 04-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 04-07-2026 | 2026-00252419 | |
| 31-12-2024 | micro format | 21-07-2025 | 2025-00291599 | |
| 31-12-2023 | abbreviated format | 18-07-2024 | 2024-00258473 | |
| 31-12-2022 | abbreviated format | 12-07-2023 | 2023-00229153 | |
| 31-12-2021 | abbreviated format | 27-06-2022 | 2022-20095457 | |
| 31-12-2020 | abbreviated format | 31-08-2021 | 2021-61200235 |
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €6,346 | - | €9,926 | - | - |
| Financial fixed assets | - | - | - | €22,191 | - |
| €14,941 | €15,673 | €14,988 | €15,711 | €15,711 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on DR ROBERT BOLDERMAN
The operating result for 2025 is 2% lower than in 2024.
Debt's share of the balance-sheet total rises from 2.9% to 5.3%. Equity is lower and debt is higher.
- 2021 Compared with 2020, the net result rose by 120%. The previous financial year ran 11 months, this one 12.